Antitumor agent-96
Antitumor agent-96 (Compound D34) is a potent MRE11 inhibitor. Antitumor agent-96 down-regulates the HR pathway by binding with MRE11 and suppressing its endonuclease functions. Antitumor agent-96 induces CM cells apoptosis.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 3041063-90-2
- 分子式: C27H32N2O2
- 分子量:416.56
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
MRE11[1]
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| L02 | IC50 |
25.6 μM
Compound: D34
|
Antiproliferative activity against human HL7702 cells cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay
Antiproliferative activity against human HL7702 cells cells assessed as cell growth inhibition incubated for 72 hrs by CCK8 assay
|
[PMID: 36868105] |
Antitumor agent-96 (Compound D34; 72 h) has a particular cytotoxicity selectivity in CM cells of CM-AS16 (IC50 = 2.9±0.1 μM), CRMM2 (IC50 = 0.7 ± 0.0 μM), CM2005.1 (IC50 = 1.0 ± 0.1 μM), and CRMM1 (IC50 = 1.3 ± 0.3 μM), compared to ocular melanoma, cutaneous melanoma and normal cells[1].
Antitumor agent-96 (0.1-10 μM; 48 h) induces CRMM1 cell apoptosis[1].
Antitumor agent-96 (0.3 μM; 0-72 h) inhibits CRMM1 cell migration[1].
Antitumor agent-96 (0.3-10 μM; 48 h) augments DNA damage accumulation in CM cells and down-regulates MRN complex in HR pathway[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:CM-AS16, CRMM2 , CM2005.1, CRMM1, HL7702 and PIG1
-
Concentration:
-
Incubation Time:72 h
-
Result:Inhibited proliferation with IC50s of 2.9 ± 0.1, 0.7 ± 0.0, 1.0 ± 0.1, 1.3 ± 0.3, 25.6 ± 0.8 and 32.9 ± 0.3 μM against CM-AS16, CRMM2, CM2005.1, CRMM1, HL7702 and PIG1, respectively.
-
Cell Line:CRMM1 cells
-
Concentration:0.1, 0.3, 1, 3 and 10 μM
-
Incubation Time:48 h
-
Result:Significantly led to CRMM1 cells death over the concentrations of 0.3 μM. The apoptotic rates rose to 80% when incubated at 3 μM.
-
Cell Line:CRMM1 cells
-
Concentration:0.3 μM
-
Incubation Time:0, 24, 48 and 72 h
-
Result:Inhibited migration rate from 70% to 45% at 72 h.
-
Cell Line:CRMM1 and CRMM2
-
Concentration:0.3, 1, 3 and 10 μM
-
Incubation Time:48 h
-
Result:Stimulated tumor suppressor p53. Induced significant accumulation of γ-H2AX. The three MRN subunits MRE11, RAD50, and NBS1, were significantly down-regulated in a dose-dependent manner. The expression of MRN downstream effectors, including BCRA1 and RAD51, were also inhibited in both CRMM1 and CRMM2 cells.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:NCG mice, CRMM1 xenograft tumor model[1]
-
Dosage:10 mg/kg and 20 mg/kg
-
Administration:Intraperitoneal injection, five times per week for 28 days
-
Result:Suppressed tumor growth. Did not induce any conspicuous body weight loss.
化学情報
-
CAS 番号 3041063-90-2
-
分子量 416.56
-
分子式 C27H32N2O2
-
SMILES
O=C(C1=C2C=CC=CC2=CC=C1OCCCN3CCNCC3)CCCC4=CC=CC=C4
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Antitumor agent-96 関連分類
HY-149972 関連分類
Powered by Bioz